Interaction of (S)-thalidomide molecule with four nucleobases: adenine, guanine, cytosine and thymine, is investigated in details employing density functional theory methods. Different mutual positions of the molecules are considered, with the starting geometries enabling hydrogen bond interactions between the monomers. Optimization of geometrical parameters is carried out within the B3LYP/6-311G** approximation and followed by evaluation of vibrational frequencies. Binding and interaction energies are calculated employing exchange-correlation functionals including long-range corrections and properly diffuse basis sets. The strongest interaction exists within the (S)-thalidomide-guanine complex. Interestingly, in one of the investigated (S)-thalidomide-guanine complexes two bifurcated hydrogen bonds are observed. The two hydrogens involved in one of them are bonded to a carbon atom in the α position relative to carbonyl group. The present study can be useful in the design of new anticancer and antiviral drugs interacting selectively with DNA or RNA.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.abb.2020.108566 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Direct Enantiomer Differentiation of Drugs and Drug-Like Compounds via Noncovalent Copper-Amino Acid Complexation and Ion Mobility-Mass Spectrometry.
Anal Chem
August 2024
Department of Chemistry, Center for Innovative Technology, Vanderbilt Institute of Chemical Biology, Vanderbilt-Ingram Cancer Center, and Vanderbilt Institute for Integrated Biosystems Research and Education, Vanderbilt University, Nashville, Tennessee 37235-1822, United States.
Drug enantiomers can possess vastly different pharmacological properties, yet they are identical in their chemical composition and structural connectivity. Thus, resolving enantiomers poses a great challenge in the field of separation science. Enantiomer separations necessitate interaction of the analyte with a chiral environment─in mass spectrometry-based analysis, a common approach is through a three-point interaction with a chiral selector commonly introduced during sample preparation.
View Article and Find Full Text PDFTowards understanding the interaction of (S)-thalidomide with nucleobases.
Arch Biochem Biophys
October 2020
Department of Chemical Technology and Pharmaceuticals, Faculty of Pharmacy, Collegium Medicum Nicolaus Copernicus University, 2 Jurasz St., PL-85089, Bydgoszcz, Poland. Electronic address:
Interaction of (S)-thalidomide molecule with four nucleobases: adenine, guanine, cytosine and thymine, is investigated in details employing density functional theory methods. Different mutual positions of the molecules are considered, with the starting geometries enabling hydrogen bond interactions between the monomers. Optimization of geometrical parameters is carried out within the B3LYP/6-311G** approximation and followed by evaluation of vibrational frequencies.
View Article and Find Full Text PDFEnantioselective sensing of (S)-Thalidomide in blood plasma with a chiral naphthalene diimide derivative.
Biosens Bioelectron
November 2020
Faculty of Chemistry, University of Warsaw, Pasteura 1 Str., PL-02-093, Warsaw, Poland. Electronic address:
Fast, simple in use and highly effective voltammetric enantiosensor dedicated for determination of thalidomide (TD) enantiomers (especially towards the toxic (S)-enantiomer) in blood plasma is still desirable. Here we have proven that newly synthesized chiral naphthalene diimide (NDI) derivatives are excellent electroactive materials for TD enantiosensors. The recognition process relies on the specific interaction between the chiral NDI receptor and the thalidomide enantiomer of the opposite configuration.
View Article and Find Full Text PDFModified DNA aptamer that binds the (R)-isomer of a thalidomide derivative with high enantioselectivity.
J Am Chem Soc
February 2007
Department of Applied Chemistry, Gunma University, Kiryu, Gunma 376-8515 Japan.
A thalidomide-binding aptamer was produced by systematic evolution of ligands by exponential enrichment from a library of non-natural DNA in which thymidine had been replaced with a modified deoxyuridine bearing a cationic functional group via a hydrophobic methylene linker at the C5 position. The additional functional group in the modified DNA aptamer could improve stability against nucleases and increase the binding affinity to thalidomide. The selected aptamer could recognize thalidomide enantioselectively, although a racemic thalidomide-attached gel was used for the selection.
View Article and Find Full Text PDFEnantioselectivity of thalidomide serum and tissue concentrations in a rat glioma model and effects of combination treatment with cisplatin and BCNU.
J Pharm Pharmacol
January 2007
Bill Walsh Cancer Research Laboratories, Department of Medical Oncology, University of Sydney at Royal North Shore Hospital, St Leonards, Sydney, NSW 2065, Australia.
Thalidomide is currently under evaluation as an anti-angiogenic agent in cancer treatment, alone and in combination with cytotoxic agents. Thalidomide is a racemate with known pharmacologic and pharmacokinetic enantioselectivity. In a previous study with thalidomide combination chemotherapy, we found evidence of anti-tumour synergy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!